Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. ASPIRO trial is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Parkinson's disease appears in 1 tracked Healthcare story from July 21, 2026. The tracked stories average 1 original source each.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. ASPIRO trial is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Parkinson's disease appears in 1 tracked Healthcare story from July 21, 2026. The tracked stories average 1 original source each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Parkinson's disease. Shared-story counts are live from our verified record — not editorial picks.
A novel autologous cell therapy for Parkinson's disease has been administered to 15 patients using a frozen, ready-to-inject formulation that simplifies hospital procedures. Aspen Neuroscience's approach eliminates the need for immunosuppressants and could transform chronic disease management if proven effective.
Parkinson's disease is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
